These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20163420)

  • 1. The economic impact of high-need psoriasis in daily clinical practice before and after the introduction of biologics.
    Driessen RJ; Bisschops LA; Adang EM; Evers AW; Van De Kerkhof PC; De Jong EM
    Br J Dermatol; 2010 Jun; 162(6):1324-9. PubMed ID: 20163420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasis.
    Bhosle MJ; Feldman SR; Camacho FT; Timothy Whitmire J; Nahata MC; Balkrishnan R
    J Dermatolog Treat; 2006; 17(5):294-301. PubMed ID: 17092860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of biologics on the quality of life of psoriasis patients and the economics of psoriasis care.
    Stein KR; Pearce DJ; Feldman SR
    Semin Cutan Med Surg; 2005 Mar; 24(1):52-7. PubMed ID: 15900799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resource use in patients with psoriasis after the introduction of biologics in Sweden.
    Norlin JM; Steen Carlsson K; Persson U; Schmitt-Egenolf M
    Acta Derm Venereol; 2015 Feb; 95(2):156-61. PubMed ID: 24819980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of comorbidities in patients with psoriasis is substantial.
    Kimball AB; Guérin A; Tsaneva M; Yu AP; Wu EQ; Gupta SR; Bao Y; Mulani PM
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):157-63. PubMed ID: 20561129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of psoriasis on health care costs and patient work loss.
    Fowler JF; Duh MS; Rovba L; Buteau S; Pinheiro L; Lobo F; Sung J; Doyle JJ; Swensen A; Mallett DA; Kosicki G
    J Am Acad Dermatol; 2008 Nov; 59(5):772-80. PubMed ID: 19119095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany.
    Berger K; Ehlken B; Kugland B; Augustin M
    J Dtsch Dermatol Ges; 2005 Jul; 3(7):511-8. PubMed ID: 15967010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, safety, and cost of Goeckerman therapy compared with biologics in the treatment of moderate to severe psoriasis.
    de Miguel R; el-Azhary R
    Int J Dermatol; 2009 Jun; 48(6):653-8. PubMed ID: 19538381
    [No Abstract]   [Full Text] [Related]  

  • 9. The burden of illness associated with psoriasis: cost of treatment with systemic therapy and phototherapy in the US.
    Crown WH; Bresnahan BW; Orsini LS; Kennedy S; Leonardi C
    Curr Med Res Opin; 2004 Dec; 20(12):1929-36. PubMed ID: 15701211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study.
    Schöffski O; Augustin M; Prinz J; Rauner K; Schubert E; Sohn S; Reich K
    J Dtsch Dermatol Ges; 2007 Mar; 5(3):209-18. PubMed ID: 17338796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost of hospital-related care of patients with psoriasis in Italy based on the AISP study. Associazione Italiana Studi Psoriasi.
    Finzi AF; Mantovani LG; Belisari A;
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):320-4. PubMed ID: 11730042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic Burden of Psoriasis and Potential Cost Offsets with Biologic Treatment: A Swedish Register Analysis.
    Svedbom A; Dahlén J; Mamolo C; Cappelleri JC; Mallbris L; Petersson IF; Ståhle M
    Acta Derm Venereol; 2016 Jun; 96(5):651-7. PubMed ID: 26716136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Health economic aspects of psoriasis therapy. Is inpatient topical treatment of plaque-type psoriasis in this age of biologics still appropriate from both medical and economic viewpoints?].
    Hahn M; Schulz T
    Hautarzt; 2005 Jun; 56(6):576-80. PubMed ID: 15815889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective evaluation of the cost of psoriasis in Spain (EPIDERMA project: phase II).
    Carrascosa JM; Pujol R; Daudén E; Hernanz-Hermosa JM; Bordas X; Smandia JA; Ferrándiz C
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):840-5. PubMed ID: 16898908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world US healthcare costs of psoriasis for biologic-naive patients initiating apremilast or biologics.
    Feldman SR; Pelletier CL; Wilson KL; Mehta RK; Brouillette MA; Smith D; Bonafede MM
    J Comp Eff Res; 2019 Jan; 8(1):45-54. PubMed ID: 30387367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan.
    Feldman SR; Evans C; Russell MW
    J Dermatolog Treat; 2005 Feb; 16(1):37-42. PubMed ID: 15897166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in the treatment of moderately severe scalp psoriasis in Scotland - results of a survey of Scottish health professionals.
    Smith DR; Bottomley JM; Auland M; Jackson P; Sharp J
    Curr Med Res Opin; 2011 Jan; 27(1):239-49. PubMed ID: 21142837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Satisfaction of treatment with biologics is high in psoriasis: results from the Bio-CAPTURE network.
    van den Reek JM; van Lüumig PP; Otero ME; Zweegers J; van de Kerkhof PC; Ossenkoppele PM; Njoo MD; Mommers JM; Koetsier MI; Arnold WP; Sybrandy-Fleuren BA; Kuijpers AL; Andriessen MP; Seyger MM; Kievit W; de Jong EM
    Br J Dermatol; 2014 May; 170(5):1158-65. PubMed ID: 24484403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Care of patients with psoriasis: an audit of U.K. services in secondary care.
    Eedy DJ; Griffiths CE; Chalmers RJ; Ormerod AD; Smith CH; Barker JN; Potter J; Ingham J; Lowe D; Burge S
    Br J Dermatol; 2009 Mar; 160(3):557-64. PubMed ID: 19120330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of psoriasis care in Germany--results of the national study PsoHealth 2007.
    Augustin M; Reich K; Reich C; Purwins S; Jeff Rustenbach S; Schäfer I; Radtke M
    J Dtsch Dermatol Ges; 2008 Aug; 6(8):640-5. PubMed ID: 18801145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.